| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 81,607 | 90,985 | 80,053 | | Cost of Revenue | 65,610 | 73,388 | 64,927 | | | Gross Profit | 15,998 | 17,597 | 15,126 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 18,130 | 18,171 | 16,805 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,132) | (574) | (1,679) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (2,132) | (574) | (1,679) | | Interest Expense | 37 | 59 | 36 | | Income Before Tax | (2,169) | (632) | (1,714) | | Income Tax Expense | (339) | 29 | (630) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,830) | (661) | (1,084) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,830) | (661) | (1,084) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,830) | ($661) | ($1,084) |
|
0.22% Nasdaq 
Income Statement
